Alpha 2.0
Login Register
» Authors » M B Axelsen

M B Axelsen

Explore the profile of M B Axelsen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 62
Followers 0
Related Specialties
Rheumatology
Dermatology
Top 10 Co-Authors
M Ostergaard
M Boesen
H Bliddal
O Kubassova
R P Poggenborg
K Horslev-Petersen
L G Hanson
M Stoltenberg
M L Hetland
K Kragballe
Published In
Scand J Rheumatol
Arch Dermatol
Acta Derm Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis
Axelsen M, Boesen M, Bliddal H, Jacobsson L, Hansen M, Ostergaard M
Scand J Rheumatol . 2019 Sep; 49(2):105-111. PMID: 31524046
: The aim was to explore dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as an early marker of therapeutic response in patients with rheumatoid arthritis (RA) starting treatment with certolizumab pegol...
2.
Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis
Axelsen M, Eshed I, Ostergaard M, Hetland M, Moller J, Jensen D, et al.
Scand J Rheumatol . 2017 Jan; 46(4):253-262. PMID: 28125360
Objective: To investigate changes in whole-body magnetic resonance imaging (WBMRI) inflammatory and structural lesions in most joints and entheses in patients with rheumatoid arthritis (RA) treated with adalimumab. Methods: WBMRI...
3.
Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging
Axelsen M, Ejbjerg B, Hetland M, Skjodt H, Majgaard O, Lauridsen U, et al.
Scand J Rheumatol . 2013 Nov; 43(2):109-18. PMID: 24191910
Objectives: To identify the magnetic resonance imaging (MRI) parameter that best differentiates healthy persons and patients with early rheumatoid arthritis (RA), and to investigated responsiveness to treatment of various MRI...
4.
Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis
Axelsen M, Poggenborg R, Stoltenberg M, Kubassova O, Boesen M, Horslev-Petersen K, et al.
Scand J Rheumatol . 2012 Dec; 42(2):115-22. PMID: 23249339
Objectives: To investigate the responsiveness to treatment and the reliability of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in rheumatoid arthritis (RA) knee joints. Methods: DCE-MRI was performed in 12 clinically...
5.
Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology
Axelsen M, Stoltenberg M, Poggenborg R, Kubassova O, Boesen M, Bliddal H, et al.
Scand J Rheumatol . 2012 Jan; 41(2):89-94. PMID: 22283139
Objective: To determine whether dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluated using semi-automatic image processing software can accurately assess synovial inflammation in rheumatoid arthritis (RA) knee joints. Methods: In 17...
6.
Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study
Kragballe K, Steijlen P, Ibsen H, van de Kerkhof P, Esmann J, Sorensen L, et al.
Arch Dermatol . 1995 May; 131(5):556-60. PMID: 7741542
Background And Design: Disorders of keratinization are a heterogeneous group of diseases that have in common a defect in cornification. The bioactive form of vitamin D3 has been shown to...
7.
Efficacy and safety of the 20-epi-vitamin D3 analogue KH 1060 in the topical therapy of psoriasis: results of a dose-ranging study
Kragballe K, Dam T, HANSEN E, Baadsgaard O, Gronhoj Larsen F, Sondergaard J, et al.
Acta Derm Venereol . 1994 Sep; 74(5):398-402. PMID: 7817684
KH 1060 is a 20-epi-vitamin D3 analogue, structurally related to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). In vitro, KH 1060 is much more potent than 1,25(OH)2D3 in regulating cell growth and T lymphocyte...